Paragraf is a wholly owned subsidiary of the University of Cambridge. Paragraf focuses on the production of 2D materials, primarily graphene, and the development of devices based on these materials.
Using a proprietary approach, Paragraf reported that it has overcome the problems of poor uniformity, reproducibility, limited size and material contamination that affect current graphene manufacturing techniques. Paragraf aims to deliver functionally active graphene with properties specifically targeted at its application.
In September 2017, Paragraf closed a £2.64 million seed round to support the development of its first major products. The round was led by Cambridge Enterprise, the commercialization arm of the University of Cambridge, with the participation of Parkwalk Advisors, Amadeus Capital Partners, IQ Capital Partners, Martlet, the investment arm of Marshall of Cambridge Group, and a small group of angel investors.